title: Is bcl-2 a key molecule in the abnormal immune response of hemodialysis patients?
authors.forename: A
authors.initials: A
authors.lastname: Martin-Malo
authors.forename: R
authors.initials: R
authors.lastname: Ramirez
authors.forename: P
authors.initials: P
authors.lastname: Aljama
mesh_terms: D017209:Apoptosis / Q000276:immunology*; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy / Q000209:etiology / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D007674:Kidney Diseases / Q000150:complications / Q000276:immunology* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D007963:Leukocytes, Mononuclear / Q000276:immunology* / Q000473:pathology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000276:immunology*; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2